Search results
Results from the Health.Zone Content Network
McKesson expects 2024 adjusted profit of $26.55 to $27.35 per share, from a prior forecast of $26.10 to $26.90 per share. Analysts estimate a profit of $26.63. Excluding items, the company ...
Financials as of March 31, 2024. [update] [1] McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 51,000 employees.
The Texas-headquartered company forecast 2025 adjusted per-share profit of $31.25 to $32.05, above analysts' average estimate of $31.02 per share, according to LSEG data.
The company also said it had renewed a distribution agreement with its largest client, CVS Health Inc, through 2023. "McKesson reported mixed end to its FY19, but in this environment that is ...
Profits (USD millions) 1 Apple: Electronics 99,803 2 Microsoft: Technology 72,738 3 Alphabet: Technology 59,972 5 ExxonMobil: Petroleum industry 55,740 6 JPMorgan Chase: Financials 37,676 7 Chevron Corporation: Petroleum industry 35,465 8 Pfizer: Pharmaceutical industry 31,372 9 Bank of America: Financials 27,528 10 Meta Platforms: Technology ...
The McKesson & Robbins, Inc. scandal of 1938 was one of the major financial scandals of the 20th century. The company McKesson & Robbins, Inc. (now McKesson Corporation) had been taken over in 1925 by Phillip Musica, who had previously used Adelphia Pharmaceutical Manufacturing Company as a front for bootlegging operations.
McKesson Europe AG (formerly Celesio AG, previously Gehe AG), with its headquarters in Stuttgart, Germany, is a leading international wholesale and retail company and provider of logistics and services in the pharmaceutical and healthcare sectors. The company had around 37,000 employees at the end of the 2019 financial year (31 March 2019) and ...
McKesson owns approximately 70% of the new company, with the remaining equity stake held by Change Healthcare stockholders. The new company continues to be called Change Healthcare. In October 2018, it was reported that Change Healthcare Corporation hired underwriters and investment banks for a 2018/2019 time-frame initial public offering.